Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Novartis patents chondrogenesis inducers

July 1, 2020

FDA clears IND for RP-L401 gene therapy for infantile malignant osteopetrosis

June 30, 2020

Janssen discontinues phase III LOTUS study of ustekinumab in SLE

June 29, 2020

Novartis presents compounds for arthritis

June 26, 2020

Tarapeutics Science patents PI3Kdelta inhibitors

June 22, 2020

FDA approves Cosentyx for active nonradiographic axial spondyloarthritis

June 17, 2020

Ilaris approved in U.S. for active Still's disease

June 17, 2020

Netakimab demonstrates superiority to placebo in second-line psoriatic arthritis

June 17, 2020

Domain Therapeutics' biased PAR2 inhibitors show antiarthritic effects

June 11, 2020

AbbVie reports new phase IIa data on ABBV-3373 in moderate to severe rheumatoid arthritis

June 11, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...